Schlafen 11 as a prognostic and potentially predictive biomarker in soft tissue sarcoma: evidence from a real-world cohort

BackgroundSoft tissue sarcomas (STS) carry a high risk of relapse or metastasis even after complete resection. (Neo-)adjuvant chemotherapy benefits only a subset of patients, underscoring the need for predictive biomarkers. Schlafen 11 (SLFN11) has emerged as a marker of sensitivity to DNA-damaging...

Volledige beschrijving

Bibliografische gegevens

Hoofdauteurs:	Adrian Georg Simon, Su Ir Lyu, David Stahl, Lars Mortimer Schiffmann, Birte Wenk, Reinhard Buettner, Nora Wuerdemann, Armin Tuchscherer, Roland Tillmann Ullrich, Alexander Quaas
Formaat:	Artigo
Taal:	Inglês
Gepubliceerd in:	Frontiers Media S.A. 2026-03-01
Reeks:	Frontiers in Oncology
Onderwerpen:	soft tissue sarcoma Schlafen 11 SLFN11 predictive biomarker prognostic biomarker trabectedin
Online toegang:	https://www.frontiersin.org/articles/10.3389/fonc.2026.1792367/full
Tags:	Voeg label toe Geen labels, Wees de eerste die dit record labelt!